These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 11399669)

  • 1. The C6-2B glioma cell P2Y(AC) receptor is pharmacologically and molecularly identical to the platelet P2Y(12) receptor.
    Jin J; Tomlinson W; Kirk IP; Kim YB; Humphries RG; Kunapuli SP
    Br J Pharmacol; 2001 Jun; 133(4):521-8. PubMed ID: 11399669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular cloning of the platelet P2T(AC) ADP receptor: pharmacological comparison with another ADP receptor, the P2Y(1) receptor.
    Takasaki J; Kamohara M; Saito T; Matsumoto M; Matsumoto S; Ohishi T; Soga T; Matsushime H; Furuichi K
    Mol Pharmacol; 2001 Sep; 60(3):432-9. PubMed ID: 11502873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of adenosine diphosphates and triphosphates on a P2Y(T) -type receptor in brain capillary endothelial cells.
    Simon J; Vigne P; Eklund KM; Michel AD; Carruthers AM; Humphrey PP; Frelin C; Barnard EA
    Br J Pharmacol; 2001 Jan; 132(1):173-82. PubMed ID: 11156575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological and second messenger signalling selectivities of cloned P2Y receptors.
    Nicholas RA; Lazarowski ER; Watt WC; Li Q; Boyer J; Harden TK
    J Auton Pharmacol; 1996 Dec; 16(6):319-23. PubMed ID: 9131407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2-Alkylthio-substituted platelet P2Y12 receptor antagonists reveal pharmacological identity between the rat brain Gi-linked ADP receptors and P2Y12.
    Vasiljev KS; Uri A; Laitinen JT
    Neuropharmacology; 2003 Jul; 45(1):145-54. PubMed ID: 12814667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the platelet P2Y12 receptor for adenosine diphosphate potentiates the antiplatelet effect of prostacyclin.
    Cattaneo M; Lecchi A
    J Thromb Haemost; 2007 Mar; 5(3):577-82. PubMed ID: 17155953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclic analogues of adenosine bisphosphates as P2Y receptor antagonists: phosphate substitution leads to multiple pathways of inhibition of platelet aggregation.
    Xu B; Stephens A; Kirschenheuter G; Greslin AF; Cheng X; Sennelo J; Cattaneo M; Zighetti ML; Chen A; Kim SA; Kim HS; Bischofberger N; Cook G; Jacobson KA
    J Med Chem; 2002 Dec; 45(26):5694-709. PubMed ID: 12477353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the mechanism of plasmin-induced platelet aggregation. Implications of the dual role of granule ADP.
    Ishii-Watabe A; Uchida E; Mizuguchi H; Hayakawa T
    Biochem Pharmacol; 2000 Jun; 59(11):1345-55. PubMed ID: 10751543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.
    Storey RF; Sanderson HM; White AE; May JA; Cameron KE; Heptinstall S
    Br J Haematol; 2000 Sep; 110(4):925-34. PubMed ID: 11054084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADP-evoked phospholipase C stimulation and adenylyl cyclase inhibition in glioma C6 cells occur through two distinct nucleotide receptors, P2Y(1) and P2Y(12).
    Czajkowski R; Lei L; Sabała P; Barańska J
    FEBS Lett; 2002 Feb; 513(2-3):179-83. PubMed ID: 11904146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenine triphosphate nucleotides are antagonists at the P2Y receptor.
    Kauffenstein G; Hechler B; Cazenave JP; Gachet C
    J Thromb Haemost; 2004 Nov; 2(11):1980-8. PubMed ID: 15550030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The P2 receptors and congenital platelet function defects.
    Cattaneo M
    Semin Thromb Hemost; 2005 Apr; 31(2):168-73. PubMed ID: 15852220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis for ADP-induced platelet activation. II. The P2Y1 receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets.
    Jin J; Daniel JL; Kunapuli SP
    J Biol Chem; 1998 Jan; 273(4):2030-4. PubMed ID: 9442040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y1-receptors in human platelets which are pharmacologically distinct from P2Y(ADP)-receptors.
    Fagura MS; Dainty IA; McKay GD; Kirk IP; Humphries RG; Robertson MJ; Dougall IG; Leff P
    Br J Pharmacol; 1998 May; 124(1):157-64. PubMed ID: 9630355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a P2Y-purinergic receptor that inhibits adenylyl cyclase.
    Boyer JL; Lazarowski ER; Chen XH; Harden TK
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1140-6. PubMed ID: 8263774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both the ADP receptors P2Y1 and P2Y12, play a role in controlling shape change in human platelets.
    Jagroop IA; Burnstock G; Mikhailidis DP
    Platelets; 2003 Feb; 14(1):15-20. PubMed ID: 12623443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of the platelet ADP receptor targeted by antithrombotic drugs.
    Hollopeter G; Jantzen HM; Vincent D; Li G; England L; Ramakrishnan V; Yang RB; Nurden P; Nurden A; Julius D; Conley PB
    Nature; 2001 Jan; 409(6817):202-7. PubMed ID: 11196645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270.
    Ding Z; Kim S; Dorsam RT; Jin J; Kunapuli SP
    Blood; 2003 May; 101(10):3908-14. PubMed ID: 12560222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenosine diphosphate (ADP)-induced thromboxane A(2) generation in human platelets requires coordinated signaling through integrin alpha(IIb)beta(3) and ADP receptors.
    Jin J; Quinton TM; Zhang J; Rittenhouse SE; Kunapuli SP
    Blood; 2002 Jan; 99(1):193-8. PubMed ID: 11756171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P2Y12 receptor stimulation inhibits beta-adrenergic receptor-induced differentiation by reversing the cyclic AMP-dependent inhibition of protein kinase B.
    Van Kolen K; Slegers H
    J Neurochem; 2004 Apr; 89(2):442-53. PubMed ID: 15056287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.